November saw the CLAHRC hold its biggest engagement event so far with a major research showcase event at Hamilton House in central London. We invited our partners from across the NHS, local government and the voluntary sector, offering them the chance to meet researchers and find out more about what we do in a relaxed informal setting.
Over sixty external visitors from across our partnership joined CLAHRC researchers, staff and patient/public contributors across the day-long event, split into morning and afternoon sessions to give visitors more chance to come along before and after work.
The exhibition style event allowed visitors to view over fifty posters for all CLAHRC research studies and PhD projects.
We invited six PPI/E ambassadors to help us run the event. Our public/patient contributors came from the CLAHRC’s Research Advisory Panel and individual CLAHRC projects and spoke to visitors about their involvement in our work.
It was also a chance for our partners to let us know the big issues they were facing in front-line NHS and public health care as well as offer their views on what CLAHRC research priorities should be. Our Research Partnership Team was on hand to talk to visitors about potential future research collaborations.
Our thanks to all who came along.
Professor Jonathan Grigg is one of the UK’s top paediatricians and an international leader in paediatric respiratory research. Since 2003, he has obtained over £11M in research grants as PI and co-applicant from MRC, NIHR, DH and charities. These funds supported air pollution and asthma research with national and international impact. He is the lead paediatrician for government advice on air pollution and children’s health as a member of the Committee on the Medical Effects of Air Pollution, and provides ad hoc advice on respiratory toxicity to the Committee on Carcinogens. He co-chairs the Royal College of Physicians Committee into “air pollution throughout the life course”. In leading the national paediatric research agenda, he organises all paediatric input into British Thoracic Society’s meetings, and as elected secretary to the Royal College Paediatrics and Child Health’s Academic Board, organises its Annual Meeting. He develops national research priorities in paediatric respiratory medicine as Chair of the British Paediatric Respiratory Society, ex chair and, now member, of the Clinical Study Group (Respiratory) for the Medicines for Children network, NIHR Programme Grant Experts Panel. He leads on paediatric respiratory infection and immunology as elected chair of this group in the European Respiratory Society. Nationally, he evaluates the cost effectiveness of therapies, as the paediatric lead of NICE Appraisal Panel A, and is an RCPCH-appointed expert adviser on asthma therapies to other appraisal panels. Locally, he leads on paediatric non-medicines research in NE London as regional LCRN representative to the national committee, and supports academic training as the RCPCH regional academic advisor.